Suboxone Tooth Decay


Suboxone, a buprenorphine medication for treating opioid use disorder, gained FDA approval and exclusive market access in 2002. The manufacturer, Indivior Inc., quickly dominated the medication-assisted treatment market, developing various forms of the drug to meet increasing demand and reduce competition.

Unfortunately, taking Suboxone sublingually (under the tongue) can cause severe dental complications, a risk that the manufacturer and its affiliates did not disclose to the public. Consequently, Suboxone users are filing product liability lawsuits, accusing the pharmaceutical companies of dishonest and irresponsible business practices.

To file a Suboxone tooth decay lawsuit, users must meet specific criteria, including qualifying prescription dates, documented medical and dental complications, and compliance with relevant statutes of limitation.

Although a warning was finally added in 2022, all Suboxone lawsuits being filed are on behalf of victims who suffered from tooth decay, broken teeth, and other dental injuries from using Suboxone before 2022, without being warned of the risks.

Potential dental issues related to Suboxone include:

  • Tooth decay
  • Tooth loss and extraction
  • Infections
  • Cracked teeth
  • Cavities
  • Root canals
  • Dental caries (loss of enamel, dentine, etc.)
  • Crown or crown replacement

Our Suboxone lawyers are actively investigating claims against the drug manufacturers for their failure to provide adequate warnings about the severe dental risks associated with Suboxone in 2024.

Contact Turnbull, Holcomb & LeMoine at 888-488-9616 or submit your case details online for a consultation. Our attorneys can offer personalized support and advocate for justice on behalf of affected people.